<DOC>
	<DOCNO>NCT01288352</DOCNO>
	<brief_summary>EAST prospectively test hypothesis early , structure rhythm control therapy base antiarrhythmic drug catheter ablation prevent atrial fibrillation ( AF ) relate complication patient AF compare usual care . Patients randomize early therapy usual care . In early therapy group , patient receive either catheter ablation ( usually pulmonary vein isolation ) , adequate antiarrhythmic drug therapy early time point . The initial therapy select local investigator . Upon AF recurrence , modality combine . Usual care conduct follow 2010European Society Cardiology ( ESC ) guideline AF treatment . Early rhythm control therapy guide Electrocardiogram ( ECG ) monitoring .</brief_summary>
	<brief_title>Early Treatment Atrial Fibrillation Stroke Prevention Trial</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Anti-Arrhythmia Agents</mesh_term>
	<criteria>1 . Recentonset AF ( ≤ 1 year prior enrolment ) 2 . At least one ECG within recent 12 month document AF whereas AF episode must last longer 30 sec . 3 . One following : age &gt; 75 year prior stroke transient ischemic attack OR two follow : age &gt; 65 year , female sex , arterial hypertension ( chronic treatment hypertension , estimate need continuous antihypertensive therapy rest blood pressure &gt; 145/90 mmHg ) , diabetes mellitus ( treat drug insulin ) impair glucose tolerance severe coronary artery disease ( previous myocardial infarction , CABG PCI ) stable heart failure ( NYHA II LVEF &lt; 50 % ) , leave ventricular hypertrophy echocardiography ( 15 mm wall thickness ) , chronic kidney disease ( MDRD stage III IV ) , peripheral artery disease . 4 . Provision sign informed consent . 5 . Age ≥ 18 year . 1 . Any disease limit life expectancy le 1 year . 2 . Participation another clinical trial , either within past two month ongoing 3 . Previous participation EAST trial . 4 . Pregnant woman woman childbearing potential adequate birth control : woman highly effective method contraception [ oral contraception intrauterine device ( IUD ) ] sterile woman randomize . 5 . Breastfeeding woman . 6 . Drug abuse . 7 . Prior AF ablation surgical therapy AF . 8 . Previous therapy failure amiodarone , e.g . patient suffer symptomatic recurrent AF require escalation therapy amiodarone . 9 . Patients suitable rhythm control AF . 10 . Severe mitral valve stenosis . 11 . Prosthetic mitral valve . 12 . Clinically relevant hepatic dysfunction require specific therapy . 13 . Clinically manifest thyroid dysfunction require therapy . After successful treatment thyroid dysfunction , patient may enrol thyroid function control . 14 . Severe renal dysfunction ( stage V , require almost require dialysis ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>early treatment</keyword>
	<keyword>rhythm control</keyword>
	<keyword>atrial fibrillation</keyword>
	<keyword>cardiovascular complication</keyword>
</DOC>